Shell Asset Management Co

SEC CIK: 0001211028
Latest filing: Nov 7, 2025

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q3 2025 holdings

Shares (Q3 2025): 1,492
Value: $22.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2025

Holdings of DNLI by Shell Asset Management Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	1,492	$22.0K	<0.1%	−2,517−62.8%	Reduced	Holders
Q2 2025	4,009	$56.0K	<0.1%	−447−10.0%	Reduced	Holders
Q1 2025	4,456	$61.0K	<0.1%	+4,456	New	Holders